Since high TSPX expression levels are associated with lower tumor grades and better survival in lung adenocarcinoma patients, our findings suggest that TSPX plays a critical role as an X-located tumor suppressor that represses the development and progression of lung adenocarcinoma. Here, TSPYL2 is linked to lung adenocarcinoma.